Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-15

FDA Approved: ZOLMITRIPTAN — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for zolmitriptan from Zydus Pharmaceuticals USA Inc., making a generic version available for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)